The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,670.00
Bid: 1,670.50
Ask: 1,671.00
Change: 17.00 (1.03%)
Spread: 0.50 (0.03%)
Open: 1,650.00
High: 1,677.00
Low: 1,646.00
Prev. Close: 1,653.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

31 Aug 2023 15:16

RNS Number : 0027L
GSK PLC
31 August 2023
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BN7SWP63

Issuer Name

GSK PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights; An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

The Goldman Sachs Group, Inc.

City of registered office (if applicable)

Wilmington, Delaware

Country of registered office (if applicable)

USA

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

28-Aug-2023

6. Date on which Issuer notified

30-Aug-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

0.200188

1.245935

1.446123

59218837

Position of previous notification (if applicable)

0.196168

6.279741

6.475909

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BN7SWP63

4154252

0.101447

US37733W2044

4043456

0.098741

Sub Total 8.A

8197708

0.200188%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Securities Lending

Open

335953

0.008204

Call Option

19-Jan-2024

971900

0.023734

Sub Total 8.B1

1307853

0.031938%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Future

15-Sep-2023

Cash

21136262

0.516147

Future

15-Dec-2023

Cash

14899402

0.363843

Future

20-Dec-2024

Cash

7091644

0.173178

Call Option

15-Dec-2023

Cash

2118886

0.051743

Future

18-Dec-2026

Cash

1240310

0.030288

Future

17-Dec-2027

Cash

958707

0.023412

Swap

15-Dec-2023

Cash

533475

0.013027

Put Option

15-Dec-2023

Cash

418124

0.010211

Put Option

20-Dec-2024

Cash

110107

0.002689

Call Option

20-Dec-2024

Cash

99861

0.002439

Put Option

15-Sep-2023

Cash

84361

0.002060

Forward

15-Sep-2023

Cash

75531

0.001844

Future

19-Dec-2025

Cash

64277

0.001570

Call Option

19-Dec-2025

Cash

62225

0.001520

Put Option

21-Jun-2024

Cash

54339

0.001327

Swap

15-Sep-2023

Cash

46463

0.001135

Forward

31-Aug-2023

Cash

43678

0.001067

Put Option

15-Mar-2024

Cash

42961

0.001049

Call Option

15-Dec-2028

Cash

38280

0.000935

Swap

19-Apr-2027

Cash

35930

0.000877

Call Warrant

31-Dec-2030

Cash

29442

0.000719

Swap

27-Jul-2033

Cash

28579

0.000698

Put Option

09-May-2024

Cash

27828

0.000680

Forward

30-Aug-2023

Cash

27474

0.000671

Put Option

19-Dec-2025

Cash

24864

0.000607

Call Option

09-May-2024

Cash

23912

0.000584

Call Option

15-Sep-2023

Cash

23422

0.000572

Put Option

23-Jan-2026

Cash

22345

0.000546

Call Option

20-Dec-2030

Cash

21242

0.000519

Call Option

17-Jan-2025

Cash

19916

0.000486

Call Option

20-Oct-2023

Cash

16621

0.000406

Put Option

16-Jun-2028

Cash

16456

0.000402

Call Option

21-Jun-2024

Cash

16343

0.000399

Put Option

17-Nov-2025

Cash

15891

0.000388

Put Option

15-Dec-2028

Cash

15012

0.000367

Call Option

08-Sep-2023

Cash

13606

0.000332

Put Option

18-Jun-2027

Cash

11546

0.000282

Swap

15-Jul-2025

Cash

11187

0.000273

Call Option

21-Feb-2025

Cash

11145

0.000272

Swap

09-Nov-2023

Cash

10849

0.000265

Put Option

02-Dec-2024

Cash

10048

0.000245

Put Option

03-Feb-2027

Cash

9751

0.000238

Swap

17-Aug-2033

Cash

9130

0.000223

Swap

03-Aug-2026

Cash

6972

0.000170

Call Option

22-May-2028

Cash

6811

0.000166

Swap

18-Aug-2025

Cash

6470

0.000158

Forward

05-Sep-2023

Cash

6055

0.000148

Forward

01-Sep-2023

Cash

6034

0.000147

Put Option

19-Sep-2025

Cash

5916

0.000144

Call Option

20-Jul-2026

Cash

5595

0.000137

Call Option

22-May-2026

Cash

5314

0.000130

Call Option

01-Apr-2026

Cash

5010

0.000122

Put Option

20-Dec-2030

Cash

4931

0.000120

Call Option

17-Dec-2032

Cash

4604

0.000112

Call Option

10-Sep-2026

Cash

4547

0.000111

Call Option

13-Oct-2023

Cash

4267

0.000104

Call Option

22-Feb-2027

Cash

4245

0.000104

Call Option

18-Dec-2026

Cash

4238

0.000103

Forward

29-Aug-2023

Cash

4119

0.000101

Put Option

14-Jul-2027

Cash

2800

0.000068

Call Option

26-Oct-2026

Cash

2794

0.000068

Call Option

30-Apr-2029

Cash

2554

0.000062

Put Option

25-Jun-2026

Cash

2379

0.000058

Put Option

13-Jan-2028

Cash

2351

0.000057

Call Option

08-Apr-2024

Cash

2312

0.000056

Put Option

06-Jun-2024

Cash

2051

0.000050

Call Option

19-Sep-2025

Cash

1995

0.000049

Swap

22-Aug-2033

Cash

1991

0.000049

Call Option

28-Mar-2025

Cash

1920

0.000047

Put Option

17-Sep-2027

Cash

1872

0.000046

Put Option

19-Mar-2027

Cash

1865

0.000046

Call Option

28-Jun-2028

Cash

1850

0.000045

Put Option

17-Dec-2027

Cash

1849

0.000045

Put Option

13-Jan-2027

Cash

1666

0.000041

Call Option

15-Mar-2024

Cash

1559

0.000038

Put Option

18-Sep-2026

Cash

1547

0.000038

Put Option

19-Jun-2026

Cash

1537

0.000038

Put Option

18-Dec-2026

Cash

1534

0.000037

Put Option

20-Mar-2026

Cash

1523

0.000037

Call Option

12-May-2025

Cash

1469

0.000036

Put Option

20-Jun-2025

Cash

1454

0.000035

Put Option

20-Sep-2024

Cash

1414

0.000035

Put Option

21-Mar-2025

Cash

1364

0.000033

Call Option

08-Apr-2025

Cash

1230

0.000030

Call Option

06-Jun-2024

Cash

1184

0.000029

Call Option

10-Jan-2029

Cash

1141

0.000028

Call Option

30-Jun-2028

Cash

1036

0.000025

Call Option

12-Jul-2024

Cash

987

0.000024

Call Option

02-Nov-2027

Cash

951

0.000023

Call Option

31-Jul-2028

Cash

777

0.000019

Call Option

29-Sep-2023

Cash

726

0.000018

Call Option

22-Sep-2023

Cash

601

0.000015

Swap

24-Nov-2023

Cash

574

0.000014

Future

19-Dec-2024

Cash

528

0.000013

Call Option

02-Nov-2028

Cash

393

0.000010

Call Option

20-Apr-2028

Cash

275

0.000007

Swap

28-Aug-2025

Cash

243

0.000006

Call Option

10-Jan-2028

Cash

203

0.000005

Call Option

11-Mar-2027

Cash

126

0.000003

Put Option

16-Feb-2024

Cash

72

0.000002

Future

14-Dec-2023

Cash

19

0.000000

Sub Total 8.B2

49713276

1.213997%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

The Goldman Sachs Group, Inc. (Chain 1)

The Goldman Sachs Group, Inc. (Chain 1)

Goldman Sachs (UK) L.L.C.

The Goldman Sachs Group, Inc. (Chain 1)

Goldman Sachs Group UK Limited

The Goldman Sachs Group, Inc. (Chain 1)

Goldman Sachs International

The Goldman Sachs Group, Inc. (Chain 2)

The Goldman Sachs Group, Inc. (Chain 2)

GSAM Holdings LLC

The Goldman Sachs Group, Inc. (Chain 2)

Goldman Sachs Asset Management Holdings LLC

The Goldman Sachs Group, Inc. (Chain 2)

Goldman Sachs Asset Management UK Holdings I Ltd

The Goldman Sachs Group, Inc. (Chain 2)

Goldman Sachs Asset Management UK Holdings II Ltd

The Goldman Sachs Group, Inc. (Chain 2)

Goldman Sachs Asset Management Holdings I B.V. / Goldman Sachs Asset Management Holdings II B.V.

The Goldman Sachs Group, Inc. (Chain 2)

Goldman Sachs Asset Management Holdings B.V.

The Goldman Sachs Group, Inc. (Chain 3)

The Goldman Sachs Group, Inc. (Chain 3)

Goldman Sachs Bank USA

The Goldman Sachs Group, Inc. (Chain 3)

Goldman Sachs Bank Europe SE

The Goldman Sachs Group, Inc. (Chain 4)

The Goldman Sachs Group, Inc. (Chain 4)

Goldman Sachs & Co. LLC

The Goldman Sachs Group, Inc. (Chain 5)

The Goldman Sachs Group, Inc. (Chain 5)

GSAM Holdings LLC

The Goldman Sachs Group, Inc. (Chain 5)

Goldman Sachs Asset Management, L.P.

The Goldman Sachs Group, Inc. (Chain 6)

The Goldman Sachs Group, Inc. (Chain 6)

IMD Holdings LLC

The Goldman Sachs Group, Inc. (Chain 6)

United Capital Financial Partners, Inc.

The Goldman Sachs Group, Inc. (Chain 6)

United Capital Financial Advisers, LLC

The Goldman Sachs Group, Inc. (Chain 7)

The Goldman Sachs Group, Inc. (Chain 7)

Goldman Sachs (UK) L.L.C.

The Goldman Sachs Group, Inc. (Chain 7)

Goldman Sachs Group UK Limited

The Goldman Sachs Group, Inc. (Chain 7)

Goldman Sachs International Bank

The Goldman Sachs Group, Inc. (Chain 8)

The Goldman Sachs Group, Inc. (Chain 8)

The Goldman Sachs Group, Inc.

The Goldman Sachs Group, Inc. (Chain 8)

The Goldman Sachs Trust Company, National Association

The Goldman Sachs Group, Inc. (Chain 8)

The Goldman Sachs Trust Company of Delaware

The Goldman Sachs Group, Inc. (Chain 9)

The Goldman Sachs Group, Inc. (Chain 9)

Goldman Sachs Financial Markets L.L.C.

The Goldman Sachs Group, Inc. (Chain 9)

Goldman Sachs Financial Markets, L.P.

The Goldman Sachs Group, Inc. (Chain 10)

The Goldman Sachs Group, Inc. (Chain 10)

Murray Street Corporation

The Goldman Sachs Group, Inc. (Chain 10)

Benson Street Limited

The Goldman Sachs Group, Inc. (Chain 11)

The Goldman Sachs Group, Inc. (Chain 11)

Folio Financial, Inc.

The Goldman Sachs Group, Inc. (Chain 11)

Folio Investments Inc.

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Please note, positions previously reportable are now exempt under the market making exemption as they are below the 10% limit.Please note, the total amount of voting rights has been rounded to 6 decimal places therefore there is a possibility of a rounding error.General email contact: gs-regops-emea-position-enquiries@gs.com

12. Date of Completion

30-Aug-2023

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLWPUPGRUPWGCG
Date   Source Headline
24th Apr 20247:00 amRNSUS FDA accepts new indication filing for Jemperli
19th Apr 20243:30 pmRNSDirector/PDMR Shareholding
17th Apr 20243:30 pmRNSDirector/PDMR Shareholding
17th Apr 20247:05 amRNSGSK announces additional EAGLE-1 results
17th Apr 20247:00 amRNSResults from long-term data relating to Shingrix
16th Apr 20242:11 pmRNSAmendment - Director/PDMR Shareholding
16th Apr 20247:00 amRNSFDA accepts GSK meningitis vaccine candidate file
15th Apr 20243:30 pmRNSDirector/PDMR Shareholding
4th Apr 202412:05 pmRNSReplacement - Total Voting Rights
2nd Apr 20243:00 pmRNSTotal Voting Rights
26th Mar 20243:30 pmRNSDirector/PDMR Shareholding
25th Mar 20241:00 pmRNSNotice of AGM
22nd Mar 20244:20 pmRNSTransfer of Treasury Shares
22nd Mar 20243:36 pmRNSDirector/PDMR Shareholding
18th Mar 20249:30 amRNSNew Phase III Jemperli data in endometrial cancer
13th Mar 20243:48 pmRNSDirector/PDMR Shareholding
8th Mar 20245:12 pmRNSBoard Committee Change
7th Mar 20247:00 amRNSGSK announces positive Blenrep DREAMM-8 results
6th Mar 20244:00 pmRNSViiV LAI vs oral SOC data in adherence-challenged
5th Mar 20245:24 pmRNSGSK Annual Report 2023 on Form 20-F
5th Mar 20247:00 amRNSNew ViiV LA formulation potential 4-month dosing
1st Mar 20243:00 pmRNSTotal Voting Rights
1st Mar 202412:15 pmRNSGSK publishes Annual Report 2023
29th Feb 20247:05 amRNSDirectorate Change
29th Feb 20247:00 amRNSStatement: Zantac (ranitidine) litigation
26th Feb 20243:30 pmRNSDirector/PDMR Shareholding
26th Feb 20247:00 amRNSGSK announces positive EAGLE-1 headline results
22nd Feb 20243:30 pmRNSDirector/PDMR Shareholding
21st Feb 20247:00 amRNSViiV LAI superior to orals in adherence-challenged
20th Feb 20249:01 amRNSJulie Brown - External Appointment
19th Feb 20243:30 pmRNSDirector/PDMR Shareholding
15th Feb 20243:32 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSGSK completes acquisition of Aiolos Bio
13th Feb 20244:45 pmRNSDirector/PDMR Shareholding - Replacement
13th Feb 20243:40 pmRNSDirector/PDMR Shareholding
13th Feb 20243:35 pmRNSDirector/PDMR Shareholding
13th Feb 20243:30 pmRNSDirector/PDMR Shareholding
6th Feb 20247:10 amRNSFDA accepts Arexvy filing for adults 50-59 at risk
6th Feb 20247:05 amRNSShingrix 18+ at risk China filing review accepted
6th Feb 20247:00 amRNSGSK presents positive DREAMM-7 phase III data
1st Feb 20243:30 pmRNSDirector/PDMR Shareholding
1st Feb 20243:00 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNSStatement: Zantac (ranitidine) litigation
31st Jan 20247:00 amRNSFinal Results
29th Jan 20247:05 amRNSEMA accepts Arexvy filing for adults 50-59 at risk
29th Jan 20247:00 amRNSEuropean Commission authorises Omjjara in the EU
19th Jan 20243:30 pmRNSDirector/PDMR Shareholding
18th Jan 20245:00 pmRNSHolding(s) in Company
17th Jan 20243:30 pmRNSDirector/PDMR Shareholding
17th Jan 20247:00 amRNSGSK completes sale of shares in Haleon plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.